Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Steven Fuller
Advertisement
Steven Fuller, PhD, is chief operating officer at Panacea Pharmaceuticals.
Articles by Steven Fuller
Advertisement
Latest Updated Articles
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
3
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
